J Gynecol Oncol.
2013 Oct;24(4):293-294. 10.3802/jgo.2013.24.4.293.
Staging of ovarian cancer: time to subdivide more?
- Affiliations
-
- 1Department Obstetrics & Gynaecology, University of Cape Town/Groote Schuur Hospital, Cape Town, South Africa. lynette.denny@uct.ac.za
- KMID: 2177867
- DOI: http://doi.org/10.3802/jgo.2013.24.4.293
Abstract
- No abstract available.
Reference
-
1. Suh DH, Kim TH, Kim JW, Kim SY, Kim HS, Lee TS, et al. Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture. J Gynecol Oncol. 2013; 24:352–358.2. Kim HS, Ahn JH, Chung HH, Kim JW, Park NH, Song YS, et al. Impact of intraoperative rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: a meta-analysis. Eur J Surg Oncol. 2013; 39:279–289.3. Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to stage I/II patients and superior survival to other stage III patients. Cancer. 1998; 83:1555–1560.4. Kanazawa K, Suzuki T, Tokashiki M. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol. 1999; 73:237–241.
